Sponsor Dossier

Baxter Healthcare

Sponsor Dossier for Baxter Healthcare. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.

About

Baxter Healthcare is an Australian Private Company with ABN 43000392781, registered in New South Wales. The entity status is Active.

Portfolio

Baxter Healthcare has 61 brands on the ARTG, of which 46 are indexable and 46 carry a Product Information document. 8 brands are PBS-listed, 0 have a PBAC outcome on record, and 4 have an AusPAR on record. Notable brands include ADENOSINE, ADSINE, AERRANE, ANESIA, ARTISS, Baxter, BORTEZOMIB, BUPIVACAINE-BAXTER, CAELYX, CERNEVIT, Citrate, CLINOLEIC.

Therapeutic focus

— Other: 17 brands — Oncology: 12 brands — Cardiology: 8 brands — Gastroenterology: 6 brands — Infectious Disease: 6 brands — Pain Management: 4 brands — Renal: 3 brands — Neurology: 3 brands — Reproductive Health: 1 brand — Haematology: 1 brand

PBS footprint

8 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.

Regulatory activity

The latest PBAC outcome is 2017-03-01, across 0 brands with a PBAC outcome on record. The latest AusPAR is 2013-10-29, across 4 brands with an AusPAR on record.

ABR record